Loss of viral gene expression and retention of tumorigenicity by Abelson lymphoma cells.

AUTOR(ES)

Grunwald, D J

RESUMO

Lymphomas induced by the Abelson murine leukemia virus (A-MuLV) were examined for the expression of biochemical and biological markers associated with A-MuLV transformation before and after in vivo growth in genetically distinguishable host mice. Although all tumors and clonal lines derived from them initially expressed the A-MuLV-encoded gag fusion protein p160, they ceased synthesis of this molecule after several weeks of growth in vivo as ascites tumors. Transplanted clonal lines continued to express the alloantigenic marker H-2b and the isoenzyme marker Gpi-1b of the donor tumor cells, indicating that the cells were of donor and not host origin. Examination of cellular DNA obtained from p160-positive and derivative p160-negative lines indicated that p160-negative clones had lost A-MuLV-specific proviral sequences as detected by hybridization with several probes. Although the clonal lines no longer expressed p160, they retained their malignant phenotype and continued to express the Abelson antigen, a cell surface marker associated with A-MuLV lymphomagenesis. Continued expression of the A-MuLV genome was not required for maintenance of oncogenic potential under these conditions of in vivo tumor growth.

Documentos Relacionados

• Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.
• Rates of aggregation, loss of anchorage dependence, and tumorigenicity of cultured cells.
• DNA methylation and viral gene expression in adenovirus-transformed and -infected cells.
• Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells.
• Virus production by Abelson murine leukemia virus-transformed lymphoid cells.